Genome-wide association study of brain connectivity changes for Alzheimer’s disease SSM Elsheikh, ER Chimusa, NJ Mulder, A Crimi Scientific reports 10 (1), 1433, 2020 | 31 | 2020 |
Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine R Hassan, I Allali, FE Agamah, SSM Elsheikh, NE Thomford, C Dandara, ... Briefings in bioinformatics 22 (4), bbaa292, 2021 | 30 | 2021 |
Multi-stage Association Analysis of Glioblastoma Gene Expressions with Texture and Spatial Patterns SSM Elsheikh, S Bakas, NJ Mulder, ER Chimusa, C Davatzikos, A Crimi Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries …, 2019 | 12 | 2019 |
A genome-wide association study identifies distinct variants associated with pulmonary function among European and African ancestries from the UK Biobank M Sinkala, SSM Elsheikh, M Mbiyavanga, J Cullinan, NJ Mulder Communications Biology 6 (1), 49, 2023 | 9 | 2023 |
Relating global and local connectome changes to dementia and targeted gene expression in Alzheimer's disease SSM Elsheikh, ER Chimusa, Alzheimer's Disease Neuroimaging Initiative, ... Frontiers in human neuroscience 15, 761424, 2021 | 9 | 2021 |
Relating connectivity changes in brain networks to genetic information in Alzheimer patients S Elsheikh, ER Chimusa, N Mulder, A Crimi 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018 …, 2018 | 7 | 2018 |
A multi-scenario genome-wide medical population genetics simulation framework JW Mugo, E Geza, J Defo, SSM Elsheikh, GK Mazandu, NJ Mulder, ... Bioinformatics 33 (19), 2995-3002, 2017 | 7 | 2017 |
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia SSM Elsheikh, DJ Müller, JG Pouget Pharmacogenomics in Drug Discovery and Development, 389-425, 2022 | 6 | 2022 |
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: An exploratory study K Yoshida, VS Marshe, SSM Elsheikh, M Maciukiewicz, AK Tiwari, ... The Pharmacogenomics Journal 23 (5), 119-126, 2023 | 4 | 2023 |
Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study X Men, V Marshe, SS Elsheikh, GS Alexopoulos, P Marino, BS Meyers, ... Neuropsychobiology 82 (3), 168-178, 2023 | 4 | 2023 |
Signal from noise: Using machine learning to distil knowledge from data in biological psychiatry TP Quinn, JL Hess, VS Marshe, MM Barnett, AC Hauschild, ... PsyArXiv, 2022 | 4 | 2022 |
A primer on the use of machine learning to distil knowledge from data in biological psychiatry TP Quinn, JL Hess, VS Marshe, MM Barnett, AC Hauschild, ... Molecular psychiatry 29 (2), 387-401, 2024 | 3 | 2024 |
Bigen: integrative clinical and brain-imaging genetics analysis using structural equation model SSM Elsheikh, ER Chimusa, A Crimi, NJ Mulder bioRxiv, 2020.02. 04.934596, 2020 | 3 | 2020 |
Genome-Wide Associations of Cognitive Domains and their Correlation with Polygenic Risk Scores for Antidepressant Response in Late-Life Depression S Elsheikh, V Marshe, M Maciukiewicz, F Islam, X Men, VSM Gonçalves, ... Alzheimer's Association International Conference, 2024 | | 2024 |
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study F Islam, A Lisoway, ES Oh, LM Fiori, L Magarbeh, SSM Elsheikh, HK Kim, ... Pharmacopsychiatry, 2024 | | 2024 |
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A … F Islam, L Magarbeh, SSM Elsheikh, S Kloiber, CW Espinola, V Bhat, ... The Canadian Journal of Psychiatry 69 (3), 183-195, 2024 | | 2024 |
Mapping Epigenetic Gene Variant Dynamics: Comparative Analysis of Frequency, Functional Impact and Trait Associations in African and European Populations M Sinkala, G Retshabile, PT Mpangase, S Bamba, MK Goita, ... medRxiv, 2024.08. 11.24311816, 2024 | | 2024 |
Modelling Latent Environmental Modifiers of Polygenic Risk for Late‐Life Depression Using Structural Equation Modelling S Elsheikh, V Marshe, JL Kennedy, G Pare, CE Fischer, D Felsky, ... Alzheimer's & Dementia 19, e079235, 2023 | | 2023 |
W26. POLYGENIC RISK SCORE ANALYSIS OF ANTIDEPRESSANT TREATMENT RESPONSE: RESULTS FROM THE CAN-BIND-1 COHORT L Magarbeh, F Islam, S Elsheikh, V Marshe, SH Kennedy, DJ Mueller, ... European Neuropsychopharmacology 75, S117-S118, 2023 | | 2023 |
F5. GENE-ENVIRONMENTAL MODIFIERS USING POLYGENIC RISK AND STRUCTURAL EQUATION MODELLING IN LATE-LIFE DEPRESSION S Elsheikh, V Marshe, G Paré, JL Kennedy, D Felsky, D Mueller European Neuropsychopharmacology 75, S222-S223, 2023 | | 2023 |